Wed 25 Nov 2009 | 20:09 EST

You are here: Home > Business & Finance > Stocks > Officers and Directors

Do More With Reuters

Partner Services

Affiliate Network

Professional Products

Support (Customer Zone)

Financial Products

About Thomson Reuters

Officers and Directors For Incyte Corporation

Incyte Corporation (INCY.O) (Consolidated Issue listed on NASDAQ Global Market)

sector: Healthcare . industry: Biotechnology · View INCY on other exchanges

As of 4:00pm EST

8.46USD

Price Change

+0.74

Percent Change

+9.59%

Analyst Recommendations

Independent Research | Broker Research

Name	Age	Since	Current Position
Friedman, Paul	66	2004	President, Chief Executive Officer, Director
Schreck, Patricia	55	2003	Executive Vice President, General Counsel
Metcalf, Brian	63	2002	Executive Vice President, Chief Drug Discovery Scientist
Levy, Richard	51	2009	Executive Vice President, Chief Drug Development and Medical Officer
Andrews, Patricia	50	2008	Executive Vice President, Chief Commercial Officer
Swain, Paula	51	2002	Executive Vice President - Human Resources
Friedman, Steven	63	2009	Executive Vice President - Biology and Preclinical Development
Whitfield, Roy	55	2003	Director
Ariko, Barry	63	2001	Director
Baker, Julian	42	2001	Director
Brooke, Paul	63	2001	Director
Niblack, John	70	2006	Director
Hastings, David	47	2003	Chief Financial Officer, Executive Vice President
De Schutter, Richard	68	2004	Chairman of the Board

Find out more about INCY.O

Insider Trading

Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Labs | Journalism Handbook | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.